Boddy AV - Search Results

1

Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Cancer Chemother Pharmacol. 1996;38(2):147-54. doi: 10.1007/s002800050463. Cancer Chemother Pharmacol. 1996. PMID: 8616905

2

Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients.

Veal GJ, Cole M, Errington J, Pearson AD, Gerrard M, Whyman G, Ellershaw C, Boddy AV. Veal GJ, et al. Among authors: boddy av. Cancer Chemother Pharmacol. 2010 May;65(6):1057-66. doi: 10.1007/s00280-009-1111-9. Epub 2009 Aug 23. Cancer Chemother Pharmacol. 2010. PMID: 19701749 Clinical Trial.

3

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.

English MW, Lowis SP, Peng B, Boddy A, Newell DR, Price L, Pearson AD. English MW, et al. Br J Cancer. 1996 Mar;73(6):776-80. doi: 10.1038/bjc.1996.135. Br J Cancer. 1996. PMID: 8611379 Free PMC article.

4

Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients.

Tasso MJ, Boddy AV, Price L, Wyllie RA, Pearson AD, Idle JR. Tasso MJ, et al. Among authors: boddy av. Cancer Chemother Pharmacol. 1992;30(3):207-11. doi: 10.1007/BF00686313. Cancer Chemother Pharmacol. 1992. PMID: 1628369

5

Comparison of continuous infusion and bolus administration of ifosfamide in children.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Eur J Cancer. 1995;31A(5):785-90. doi: 10.1016/0959-8049(95)00090-6. Eur J Cancer. 1995. PMID: 7640054

6

Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patients.

Boddy AV, Proctor M, Simmonds D, Lind MJ, Idle JR. Boddy AV, et al. Eur J Cancer. 1995;31A(1):69-76. doi: 10.1016/0959-8049(94)00300-t. Eur J Cancer. 1995. PMID: 7695982

7

The kinetics of the auto-induction of ifosfamide metabolism during continuous infusion.

Boddy AV, Cole M, Pearson AD, Idle JR. Boddy AV, et al. Cancer Chemother Pharmacol. 1995;36(1):53-60. doi: 10.1007/BF00685732. Cancer Chemother Pharmacol. 1995. PMID: 7720176

8

Cyclophosphamide metabolism in children.

Yule SM, Boddy AV, Cole M, Price L, Wyllie R, Tasso MJ, Pearson AD, Idle JR. Yule SM, et al. Among authors: boddy av. Cancer Res. 1995 Feb 15;55(4):803-9. Cancer Res. 1995. PMID: 7850793

9

Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children.

Boddy AV, Yule SM, Wyllie R, Price L, Pearson AD, Idle JR. Boddy AV, et al. Cancer Res. 1993 Aug 15;53(16):3758-64. Cancer Res. 1993. PMID: 8339288

10

Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics.

Boddy AV, English M, Pearson AD, Idle JR, Skinner R. Boddy AV, et al. Eur J Cancer. 1996 Jun;32A(7):1179-84. doi: 10.1016/0959-8049(96)00019-6. Eur J Cancer. 1996. PMID: 8758250 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters